Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Masked Replacement of Sugar-Sweetened with Sugar-Free Beverages on Body Weight Increases with Initial BMI: Secondary Analysis of Data from an 18 Month Double-Blind Trial in Children.

PloS one·2016
Same author

[The Dietary Guidelines 2015 of the Health Council of the Netherlands--a commentary].

Nederlands tijdschrift voor geneeskunde·2015
Same author

Can children discriminate sugar-sweetened from non-nutritively sweetened beverages and how do they like them?

PloS one·2015
Same author

Association of dietary, circulating, and supplement fatty acids with coronary risk.

Annals of internal medicine·2014
Same author

Comment on Kahn and Sievenpiper. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? We have, but the pox on sugar is overwrought and overworked. Diabetes care 2014;37:957-962.

Diabetes care·2014
Same author

Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial.

PloS one·2013

Related Experiment Video

Updated: May 11, 2026

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid
04:10

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

Published on: March 8, 2024

[Linoleic acid and heart infarct].

Martijn B Katan1

  • 1Vrije Universiteit Amsterdam, afd. Gezondheidswetenschappen, Amsterdam. katan99@falw.vu.nl

Nederlands Tijdschrift Voor Geneeskunde
|May 30, 2013
PubMed
Summary

This study questions a re-analysis linking linoleic acid (LA) to increased heart disease risk. It suggests the original study

Area of Science:

  • Nutrition Science
  • Cardiovascular Health
  • Dietary Fat Research

Background:

  • A 2013 re-analysis of the Sydney Diet Heart Study suggested high linoleic acid (LA) intake increases coronary heart disease (CHD) risk.
  • The re-analysis attributed this risk to a potential deficiency in omega-3 fatty acids, specifically alpha-linolenic acid (ALA).

Purpose of the Study:

  • To critically evaluate the methodology and conclusions of the 2013 Sydney Diet Heart Study re-analysis.
  • To assess the validity of claims linking linoleic acid to increased cardiovascular risk based on the re-analysis.

Main Methods:

  • Review and critique of the statistical analyses applied in the re-analysis.
  • Consideration of confounding factors, including trans fat content in the intervention diet.
  • Comparison with findings from other large-scale clinical trials on fatty acid intake and cardiovascular outcomes.

Related Experiment Videos

Last Updated: May 11, 2026

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid
04:10

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

Published on: March 8, 2024

Main Results:

  • The re-analysis reported increased mortality in the linoleic acid group, though figures varied between sources.
  • Statistical significance was achieved in the re-analysis but not the original study, raising concerns about chance findings.
  • The intervention diet was noted to be high in trans fats, a potential confounder for cardiovascular risk.
  • Recent large clinical trials have not supported a benefit from increased linolenic acid intake.

Conclusions:

  • The re-analysis of the Sydney Diet Heart Study presents insufficient evidence to alter current dietary recommendations regarding linoleic acid.
  • Potential confounding factors, including trans fat intake and statistical methodology, weaken the re-analysis's conclusions.
  • Further research and robust clinical trials are needed to definitively establish the relationship between linoleic acid, alpha-linolenic acid, and cardiovascular health.